CON Quote, Financials, Valuation and Earnings

Kindly MD has a net margin of 9.06% compared to Concentra Group Holdings Parent's net margin of -156.54%. Concentra Group Holdings Parent's return on equity of 14.17% beat Kindly MD's return on equity of -201.03%.

Concentra Group Holdings Parent has a consensus price target of $29.69, signalling upside risk potential of 37.29%. On the other hand Kindly MD has an analysts' consensus of -- which suggests that it could fall by --. Given that Concentra Group Holdings Parent has higher upside potential than Kindly MD, analysts believe Concentra Group Holdings Parent is more attractive than Kindly MD.

Concentra Group Holdings Parent has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Kindly MD has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Concentra Group Holdings Parent has a quarterly dividend of $0.06 per share corresponding to a yield of 0.31%. Kindly MD offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Concentra Group Holdings Parent pays -- of its earnings as a dividend. Kindly MD pays out -- of its earnings as a dividend.

Concentra Group Holdings Parent quarterly revenues are $489.6M, which are larger than Kindly MD quarterly revenues of $647.9K. Concentra Group Holdings Parent's net income of $44.3M is higher than Kindly MD's net income of -$1M. Notably, Concentra Group Holdings Parent's price-to-earnings ratio is 23.07x while Kindly MD's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Concentra Group Holdings Parent is 1.34x versus 2.19x for Kindly MD. Usually stocks with elevated PS ratios are considered overvalued.

Pediatrix Medical Group has a net margin of 9.06% compared to Concentra Group Holdings Parent's net margin of 3.8%. Concentra Group Holdings Parent's return on equity of 14.17% beat Pediatrix Medical Group's return on equity of -30.86%.

Concentra Group Holdings Parent has a consensus price target of $29.69, signalling upside risk potential of 37.29%. On the other hand Pediatrix Medical Group has an analysts' consensus of -- which suggests that it could grow by 15.08%. Given that Concentra Group Holdings Parent has higher upside potential than Pediatrix Medical Group, analysts believe Concentra Group Holdings Parent is more attractive than Pediatrix Medical Group.

Concentra Group Holdings Parent has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Pediatrix Medical Group has a beta of 1.570, suggesting its more volatile than the S&P 500 by 56.979%.

Concentra Group Holdings Parent has a quarterly dividend of $0.06 per share corresponding to a yield of 0.31%. Pediatrix Medical Group offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Concentra Group Holdings Parent pays -- of its earnings as a dividend. Pediatrix Medical Group pays out -- of its earnings as a dividend.

Concentra Group Holdings Parent quarterly revenues are $489.6M, which are smaller than Pediatrix Medical Group quarterly revenues of $511.2M. Concentra Group Holdings Parent's net income of $44.3M is higher than Pediatrix Medical Group's net income of $19.4M. Notably, Concentra Group Holdings Parent's price-to-earnings ratio is 23.07x while Pediatrix Medical Group's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Concentra Group Holdings Parent is 1.34x versus 0.59x for Pediatrix Medical Group. Usually stocks with elevated PS ratios are considered overvalued.

Select Medical Holdings has a net margin of 9.06% compared to Concentra Group Holdings Parent's net margin of 3.16%. Concentra Group Holdings Parent's return on equity of 14.17% beat Select Medical Holdings's return on equity of 15.65%.

Concentra Group Holdings Parent has a consensus price target of $29.69, signalling upside risk potential of 37.29%. On the other hand Select Medical Holdings has an analysts' consensus of $41.40 which suggests that it could grow by 79.7%. Given that Select Medical Holdings has higher upside potential than Concentra Group Holdings Parent, analysts believe Select Medical Holdings is more attractive than Concentra Group Holdings Parent.

Concentra Group Holdings Parent has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Select Medical Holdings has a beta of 1.278, suggesting its more volatile than the S&P 500 by 27.831%.

Concentra Group Holdings Parent has a quarterly dividend of $0.06 per share corresponding to a yield of 0.31%. Select Medical Holdings offers a yield of 2.62% to investors and pays a quarterly dividend of $0.13 per share. Concentra Group Holdings Parent pays -- of its earnings as a dividend. Select Medical Holdings pays out 26.25% of its earnings as a dividend. Select Medical Holdings's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Concentra Group Holdings Parent quarterly revenues are $489.6M, which are smaller than Select Medical Holdings quarterly revenues of $1.8B. Concentra Group Holdings Parent's net income of $44.3M is lower than Select Medical Holdings's net income of $55.6M. Notably, Concentra Group Holdings Parent's price-to-earnings ratio is 23.07x while Select Medical Holdings's PE ratio is 8.91x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Concentra Group Holdings Parent is 1.34x versus 0.34x for Select Medical Holdings. Usually stocks with elevated PS ratios are considered overvalued.

The Oncology Institute has a net margin of 9.06% compared to Concentra Group Holdings Parent's net margin of -16.13%. Concentra Group Holdings Parent's return on equity of 14.17% beat The Oncology Institute's return on equity of -163.45%.

Concentra Group Holdings Parent has a consensus price target of $29.69, signalling upside risk potential of 37.29%. On the other hand The Oncology Institute has an analysts' consensus of -- which suggests that it could grow by 851.93%. Given that The Oncology Institute has higher upside potential than Concentra Group Holdings Parent, analysts believe The Oncology Institute is more attractive than Concentra Group Holdings Parent.

Concentra Group Holdings Parent has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison The Oncology Institute has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Concentra Group Holdings Parent has a quarterly dividend of $0.06 per share corresponding to a yield of 0.31%. The Oncology Institute offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Concentra Group Holdings Parent pays -- of its earnings as a dividend. The Oncology Institute pays out -- of its earnings as a dividend.

Concentra Group Holdings Parent quarterly revenues are $489.6M, which are larger than The Oncology Institute quarterly revenues of $99.9M. Concentra Group Holdings Parent's net income of $44.3M is higher than The Oncology Institute's net income of -$16.1M. Notably, Concentra Group Holdings Parent's price-to-earnings ratio is 23.07x while The Oncology Institute's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Concentra Group Holdings Parent is 1.34x versus 0.04x for The Oncology Institute. Usually stocks with elevated PS ratios are considered overvalued.